Versor Investments LP Purchases Shares of 37,100 Oscar Health, Inc. (NYSE:OSCR)

Versor Investments LP acquired a new stake in shares of Oscar Health, Inc. (NYSE:OSCR) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 37,100 shares of the company’s stock, valued at approximately $787,000.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Point72 Hong Kong Ltd bought a new stake in Oscar Health in the 2nd quarter valued at $78,000. Quest Partners LLC acquired a new stake in shares of Oscar Health during the 2nd quarter valued at about $93,000. Optimum Investment Advisors bought a new stake in Oscar Health in the third quarter valued at about $142,000. Amalgamated Bank raised its position in Oscar Health by 27.7% in the second quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock worth $106,000 after purchasing an additional 1,458 shares in the last quarter. Finally, Farallon Capital Management LLC bought a new position in Oscar Health during the first quarter worth about $164,000. 75.70% of the stock is currently owned by institutional investors.

Insider Activity at Oscar Health

In other Oscar Health news, CAO Victoria Baltrus sold 4,226 shares of Oscar Health stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $76,025.74. Following the completion of the sale, the chief accounting officer now owns 140,648 shares of the company’s stock, valued at approximately $2,530,257.52. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Oscar Health news, CAO Victoria Baltrus sold 4,226 shares of the firm’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $76,025.74. Following the transaction, the chief accounting officer now owns 140,648 shares in the company, valued at approximately $2,530,257.52. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Richard Scott Blackley sold 68,978 shares of the company’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $1,240,914.22. Following the completion of the sale, the chief financial officer now directly owns 884,213 shares of the company’s stock, valued at approximately $15,906,991.87. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 169,569 shares of company stock worth $3,007,069 over the last ninety days. Company insiders own 25.11% of the company’s stock.

Wall Street Analysts Forecast Growth

OSCR has been the subject of several analyst reports. Piper Sandler restated an “overweight” rating and set a $28.00 target price on shares of Oscar Health in a research report on Tuesday, September 10th. UBS Group began coverage on shares of Oscar Health in a research note on Monday, October 7th. They issued a “neutral” rating and a $23.00 target price on the stock. Finally, Bank of America lowered shares of Oscar Health from a “neutral” rating to an “underperform” rating and dropped their price objective for the stock from $21.00 to $13.50 in a report on Wednesday, November 6th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $22.93.

Oscar Health Stock Performance

OSCR stock opened at $13.56 on Wednesday. The company has a 50 day moving average price of $18.45 and a 200 day moving average price of $18.36. The stock has a market capitalization of $3.28 billion, a PE ratio of -228.00, a price-to-earnings-growth ratio of 31.17 and a beta of 1.67. Oscar Health, Inc. has a fifty-two week low of $6.80 and a fifty-two week high of $23.79. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.91 and a quick ratio of 0.91.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by ($0.02). The firm had revenue of $2.42 billion during the quarter, compared to the consensus estimate of $2.33 billion. Oscar Health had a net margin of 0.35% and a return on equity of 2.91%. Oscar Health’s revenue was up 68.3% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.29) EPS. Analysts forecast that Oscar Health, Inc. will post 0.02 EPS for the current year.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.